04/17/2025 3:07 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2025 3:08 PM | Upadhyay Suketu (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2025 10:10 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025 3:11 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 12:58 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 12:02 PM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 11:42 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025 3:08 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 3:08 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 12:39 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 3:17 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
02/28/2025 3:43 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:46 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:48 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:31 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:36 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 10:20 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 9:18 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 9:14 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025 3:06 PM | Ambrose Kristen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2025 3:07 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2025 3:09 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2025 3:11 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/25/2025 10:38 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025 9:59 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025 10:13 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025 3:07 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 2:45 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 3:30 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:31 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:33 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 3:21 PM | Ambrose Kristen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/18/2025 10:29 AM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025 10:34 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 3:17 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 4:14 PM | Vertex Pharmaceuticals (Filer)
| Form S-3ASR | |
02/13/2025 3:53 PM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025 3:46 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 3:48 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 3:50 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 3:52 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
02/12/2025 3:26 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 3:21 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 3:24 PM | Ambrose Kristen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 8:34 AM | FMR LLC (Filed by) Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025 10:57 AM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025 10:05 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025 8:49 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025 3:43 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:45 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:37 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:38 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:32 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:35 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2025 3:07 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 2:51 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 9:31 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024 3:15 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 1:58 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 3:11 PM | Vertex Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024 3:12 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 3:12 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 9:04 AM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:47 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:23 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 3:08 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 10:47 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 8:52 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:17 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 2:34 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 2:25 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:06 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:05 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 11:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024 12:16 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 9:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 9:23 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 3:09 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:11 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 8:54 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 8:56 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:11 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 12:56 PM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:38 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 9:50 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024 10:48 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:08 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 9:05 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 9:51 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 12:13 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
05/22/2024 3:21 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 12:45 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 2:32 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024 11:20 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:41 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:50 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024 7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |